Top Premarket Gainers

Revenue nearly doubled and net income swung positive in 2024, driven by arbitration wins and higher patient volumes. Cost controls, new hospital openings, and technology adoption position the company for continued growth.

Based on Nutex Health Inc. [NUTX] Q4 2024 Audio Transcript — Apr. 1 2025

(Updates with the stock move in the headline and the first paragraph.)

Nutex Health shares were up more than 42% in premarket activity Tuesday after the company reported overnight a swing back into the black as sales more than tripled in Q4.

The company reported Q4 diluted earnings of $11.12 per share late Monday, compared to a loss of $7.47 a year earlier.

Revenue for the quarter that ended Dec. 31 was $257.6 million, up from $69.7 million.

2024 saw revenue nearly double and net income swing positive, driven by arbitration wins and higher patient volume. Arbitration accounted for most of the revenue growth, with an 80% win rate and significant per-visit reimbursement gains. Expansion and cost control remain key priorities.

Based on Nutex Health Inc. [NUTX] Q4 2024 Audio Transcript — Apr. 1 2025

By Stephen Nakrosis

Shares of Nutex Health climbed following fourth-quarter results that topped analysts' estimates, including a significant increase in revenue.

Fourth-quarter revenue more than tripled to $257.6 million from $69.7 million a year ago. Analysts were expecting revenue of $81.1 million.

The healthcare-management and operations company said it believes its arbitration efforts, through the independent dispute resolution process, resulted in more equitable payments.

The stock was up 41%, to $66.51 a share, in after-hours trading Monday, after closing the regular session down 9%, at $47.03. Shares at one point reached $72.00 apiece in post-market trading, topping the 52-week high of $69.45 set on Feb. 14.

The Houston company reported net income for the fourth quarter of $61.7 million, and earnings per share of $11.12, compared with a loss of $31.6 million, for a loss of $7.47 per share, in the same period a year earlier.

Analysts expected a fourth-quarter loss of $600,000, or 12 cents a share, according to a survey by FactSet.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

Nutex Health reported Q4 diluted earnings Monday of $11.12 per share, compared to a loss of $7.47 a year earlier.

Revenue for the quarter ended Dec. 31 was $257.6 million, up from $69.7 million.